Silva Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	83.8	38.77	38.69	28.64	36.43	58.66
Short-Term Investments	-	64.03	88.8	152.72	225.04	211.67
Cash & Short-Term Investments	83.8	102.8	127.49	181.37	261.47	270.33
Cash Growth	-40.33%	-19.37%	-29.70%	-30.64%	-3.28%	12.90%
Accounts Receivable	194.35	229.47	255.72	257.35	255.05	269.91
Other Receivables	-	0.14	0.41	1.97	2.56	2.3
Receivables	194.35	229.62	256.13	259.32	257.61	272.21
Inventory	406.95	443.01	493.2	493.72	482.29	464.18
Other Current Assets	62.94	54.4	62.69	66.02	61.79	68.21
Total Current Assets	748.03	829.84	939.52	1,000	1,063	1,075
Property, Plant & Equipment	1,382	1,420	1,473	1,501	1,480	1,371
Other Intangible Assets	2.24	2.42	1.22	1.36	1.51	1.68
Total Assets	2,132	2,252	2,414	2,503	2,545	2,447
Accounts Payable	14.31	9.97	7.16	6.99	6.9	6.25
Accrued Expenses	19.89	9.76	11.85	12.43	16.25	15.28
Short-Term Debt	-	28.22	47.71	55.84	91.01	29.14
Current Portion of Leases	1.01	1.07	1.18	1.42	2.34	5.67
Current Income Taxes Payable	-	6.47	5.45	7.9	19.03	30.63
Other Current Liabilities	0.1	0.21	0.82	1.62	2.59	1.52
Total Current Liabilities	35.3	55.7	74.16	86.19	138.11	88.48
Long-Term Leases	1.44	2.31	3.44	4.6	5.75	7.9
Long-Term Deferred Tax Liabilities	81.02	81.27	80.68	77.86	75.68	80.3
Total Liabilities	117.76	139.28	158.28	168.65	219.54	176.68
Common Stock	1,365	1,365	1,365	1,365	1,365	1,365
Retained Earnings	649.13	748.04	890.95	969.08	960.2	905.47
Shareholders' Equity	2,014	2,113	2,256	2,334	2,325	2,270
Total Liabilities & Equity	2,132	2,252	2,414	2,503	2,545	2,447
Total Debt	2.45	31.6	52.33	61.86	99.09	42.71
Net Cash (Debt)	81.35	71.21	75.17	119.51	162.38	227.62
Net Cash Growth	-17.81%	-5.27%	-37.10%	-26.40%	-28.67%	17.48%
Net Cash Per Share	0.60	0.52	0.55	0.88	1.19	1.67
Filing Date Shares Outstanding	136.5	136.5	136.5	136.5	136.5	136.5
Total Common Shares Outstanding	136.5	136.5	136.5	136.5	136.5	136.5
Working Capital	712.73	774.14	865.35	914.23	925.05	986.45
Book Value Per Share	14.76	15.48	16.53	17.10	17.03	16.63
Tangible Book Value	2,012	2,111	2,255	2,333	2,324	2,269
Tangible Book Value Per Share	14.74	15.46	16.52	17.09	17.02	16.62
Land	-	342.77	342.77	342.77	342.77	342.77
Buildings	-	424.09	424.09	424.09	424.09	424.09
Machinery	-	1,149	1,149	1,090	1,072	998.72
Construction In Progress	-	323.28	317.67	343.47	274.25	178.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.